LTC4S Antikörper (N-Term)
Kurzübersicht für LTC4S Antikörper (N-Term) (ABIN630425)
Target
Alle LTC4S Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- LTC4 S antibody was raised against the N terminal of LTC4
-
Aufreinigung
- Purified
-
Immunogen
- LTC4 S antibody was raised using the N terminal of LTC4 corresponding to a region with amino acids MKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVY
-
-
-
-
Applikationshinweise
-
WB: 1-2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LTC1 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- LTC4S (Leukotriene C4 Synthase (LTC4S))
-
Andere Bezeichnung
- LTC4S
-
Hintergrund
- The MAPEG (Membrane Associated Proteins in Eicosanoid and Glutathione metabolism) family includes a number of human proteins, several of which are involved the production of leukotrienes. LTC4S is an enzyme that catalyzes the first step in the biosynthesis of cysteinyl leukotrienes, potent biological compounds derived from arachidonic acid. Leukotrienes have been implicated as mediators of anaphylaxis and inflammatory conditions such as human bronchial asthma.
-
Molekulargewicht
- 16 kDa (MW of target protein)
-
Pathways
- Cellular Response to Molecule of Bacterial Origin
Target
-